Sheep Pregnancy Toxemia: Diagnosis, Emergency Treatment, and Flock Prevention
This article provides veterinarians and sheep producers with evidence-based guidance on diagnosing and managing pregnancy toxemia in ewes, including emergency treatment protocols and flock-level prevention strategies. The content focuses on practical clinical decision-making using approved diagnostic tools, treatment options, and management interventions supported by peer-reviewed literature.
At a Glance: Pregnancy Toxemia in Ewes
| Clinical Parameter | Normal Ewe | Subclinical Toxemia | Clinical Toxemia |
|---|---|---|---|
| Blood beta-hydroxybutyrate (BHB) | Below 0.8 mmol/L | 0.8 to 1.6 mmol/L | Above 1.6 mmol/L |
| Blood glucose | 3.0 to 5.0 mmol/L | 2.0 to 3.0 mmol/L | Below 2.0 mmol/L |
| Urine ketones | Negative to trace | Moderate positive | Strong positive |
| Clinical signs | Alert, eating, normal behavior | Mild depression, reduced feed intake | Recumbency, blindness, teeth grinding |
| Prognosis with treatment | Not applicable | Good with early intervention | Guarded to poor |
Pathophysiology and Risk Factors
Pregnancy toxemia in sheep, also known as twin lamb disease or ovine ketosis, develops during late gestation when energy demands of the growing fetus or fetuses exceed the ewe's dietary energy intake. The condition represents a metabolic emergency characterized by hypoglycemia, hyperketonemia, and progressive neurological dysfunction.
The metabolic disturbance occurs because pregnant ewes have limited capacity to increase feed intake during late gestation due to abdominal space occupied by the gravid uterus. When energy requirements outstrip intake, the ewe mobilizes body fat reserves, leading to increased production of ketone bodies including beta-hydroxybutyrate (BHB) and acetoacetate. Research on autoregulation of alimentary and hepatic ketogenesis in sheep has demonstrated the complex metabolic pathways involved in ketone body production during negative energy balance (Journal of Dairy Science, 1986, https://doi.org/10.3168/jds.S0022-0302%2886%2980533-1).
Primary risk factors include:
- Ewes carrying multiple fetuses (twins or triplets)
- Overconditioned ewes entering late gestation
- Underconditioned ewes with inadequate body reserves
- Sudden feed changes or reduced feed availability
- Weather stress, transportation, or handling stress
- Underlying dental disease or lameness limiting feed intake
- Primiparous ewes or aged ewes with reduced feed efficiency
Studies examining pregnancy toxemia in sheep flocks have identified multiple contributing factors that increase disease incidence (Journal of the American Veterinary Medical Association, 2000, https://pubmed.ncbi.nlm.nih.gov/11128547). Understanding these risk factors allows veterinarians to target prevention efforts toward high-risk groups within the flock.
Clinical Signs and Disease Progression
Early Clinical Signs
The earliest observable changes in ewes developing pregnancy toxemia are subtle and easily missed by producers. Affected ewes separate from the flock, show reduced interest in feed, and may stand with a depressed posture. Producers often report that the ewe appears quiet or off feed before more obvious signs develop.
Progressive Clinical Signs
As ketosis worsens, clinical signs become more apparent:
- Progressive depression and lethargy
- Reduced rumen motility
- Teeth grinding (bruxism) indicating abdominal discomfort or pain
- Staggering gait or ataxia
- Partial or complete anorexia
- Decreased fecal output
Advanced Clinical Signs
Advanced pregnancy toxemia represents a medical emergency with poor prognosis:
- Recumbency (inability to stand)
- Blindness with intact pupillary light reflexes
- Head pressing against walls or fences
- Muscle tremors or fasciculations
- Opisthotonos (head drawn back)
- Coma progressing to death
Research evaluating metabolic and oxidative profiles in ovine pregnancy toxemia has demonstrated associations between specific biomarkers and disease prognosis (Tropical Animal Health and Production, 2022, https://pubmed.ncbi.nlm.nih.gov/36210359). These findings support the importance of early detection and intervention.
Diagnostic Approach
Physical Examination
Perform a complete physical examination with attention to:
- Body condition score assessment
- Hydration status
- Rumen fill and motility
- Rectal temperature (usually normal unless concurrent infection)
- Heart rate and respiratory rate
- Neurological assessment including menace response and pupillary light reflexes
- Abdominal palpation to estimate fetal number and size
Blood Beta-Hydroxybutyrate Measurement
Blood BHB concentration is the gold standard diagnostic test for pregnancy toxemia. Field studies comparing blood BHB measurement devices for diagnosis of subclinical pregnancy toxemia in sheep have validated the use of handheld ketone meters for on-farm testing (Reproduction in Domestic Animals, 2024, https://pubmed.ncbi.nlm.nih.gov/38812426).
Practical sampling considerations:
- Collect blood from the jugular vein into heparinized tubes or use a handheld meter with fresh whole blood
- Interpret results using established cutoffs for subclinical and clinical toxemia
- Repeat testing every 12 to 24 hours to monitor treatment response
- Document results in individual ewe records
Blood Glucose Measurement
Blood glucose measurement provides complementary diagnostic information. Hypoglycemia confirms negative energy balance and supports the diagnosis. However, some ewes with pregnancy toxemia may have normal or even elevated blood glucose due to stress-induced catecholamine release.
Urine Ketone Testing
Urine ketone dipsticks offer a rapid, low-cost screening tool for field use. Collect a free-catch urine sample or obtain urine via manual bladder expression. Urine ketone results correlate with blood BHB concentrations but may lag behind blood changes by 12 to 24 hours.
Differential Diagnoses
Consider and rule out other conditions that can mimic pregnancy toxemia:
- Hypocalcemia (milk fever): Usually periparturient, responds to calcium therapy
- Listeriosis: Asymmetric neurological signs, fever, history of silage feeding
- Polioencephalomalacia: Cortical blindness, responds to thiamine
- Rabies: Progressive neurological signs, public health concern
- Traumatic injuries: Spinal cord damage, pelvic fractures
- Severe parasitism: Anemia, poor body condition, diarrhea
Emergency Treatment Protocols
Initial Stabilization
Ewes presenting with recumbency or severe depression require immediate intervention. Establish intravenous access using a jugular catheter for administration of fluids and medications. The goals of emergency treatment are to correct hypoglycemia, reduce ketone body production, and support fetal viability.
Intravenous Glucose Administration
Administer glucose intravenously as a 50% dextrose solution. The dose should be calculated based on the ewe's body weight and clinical response. Monitor blood glucose levels before and after administration to guide further therapy. Repeated boluses or continuous rate infusion may be necessary for severely affected ewes.
Oral Energy Supplementation
Oral propylene glycol provides a rapidly absorbed gluconeogenic substrate that helps correct hypoglycemia and reduce ketogenesis. Administer propylene glycol orally using a dosing syringe or drench gun. Repeat dosing every 8 to 12 hours based on clinical response and blood BHB monitoring.
Alternative oral energy sources include:
- Glycerol
- Calcium propionate
- Concentrated energy feeds (corn syrup, molasses)
Fluid Therapy
Correct dehydration with intravenous or oral fluids as needed. Use balanced electrolyte solutions such as lactated Ringer's solution or Normosol-R. Add dextrose to maintenance fluids to provide continuous glucose support. Monitor hydration status through skin turgor, mucous membrane moisture, and urine output.
Corticosteroid Therapy
Corticosteroids may be used to stimulate gluconeogenesis and induce fetal maturation if delivery is anticipated. The decision to use corticosteroids should consider gestational age, fetal viability, and the ewe's clinical status. Corticosteroids are contraindicated in ewes with concurrent infections.
Cesarean Section
When medical therapy fails or when fetal death is suspected, cesarean section may be necessary to save the ewe. Indications for surgical intervention include:
- No clinical improvement after 24 to 48 hours of medical therapy
- Progressive deterioration despite treatment
- Confirmed fetal death on ultrasound
- Severe neurological signs with poor prognosis
Cesarean section carries significant anesthetic and surgical risks in metabolically compromised ewes. Discuss prognosis and treatment options with the producer before proceeding with surgery.
Monitoring Treatment Response
Track clinical response using objective parameters:
- Blood BHB concentration every 12 to 24 hours
- Blood glucose concentration every 4 to 6 hours during acute treatment
- Urine ketone levels daily
- Feed intake and rumen motility
- Ability to stand and ambulate
- Mentation and neurological status
Document all treatments, monitoring results, and clinical observations in individual ewe records. This information guides treatment adjustments and provides valuable data for flock-level prevention planning.
Flock Prevention Strategies
Body Condition Management
Maintain ewes in optimal body condition throughout the production cycle. Target body condition scores of 3.0 to 3.5 on a 5-point scale at breeding and during mid-gestation. Avoid overconditioning ewes during early gestation, as fat ewes have reduced feed intake capacity in late gestation and are more prone to ketosis.
Practical body condition management steps:
- Score body condition at weaning, breeding, mid-gestation, and pre-lambing
- Adjust feeding levels based on condition scores
- Separate thin and fat ewes for targeted feeding
- Document condition scores for individual ewes and groups
Late Gestation Nutrition
Provide adequate energy intake during the last 4 to 6 weeks of gestation when fetal growth accelerates. Energy requirements increase by 50% to 75% for ewes carrying single lambs and by 100% to 150% for ewes carrying twins or triplets.
Nutritional management considerations:
- Increase concentrate feeding gradually over 2 to 3 weeks
- Provide high-quality forage with adequate protein content
- Ensure access to clean water at all times
- Feed multiple times daily to maintain rumen function
- Monitor feed intake and adjust rations based on body condition and fetal number
Research on pregnancy toxemia in sheep and goats has emphasized the importance of nutritional management in disease prevention (Veterinary Clinics of North America: Food Animal Practice, 2023, https://pubmed.ncbi.nlm.nih.gov/37032302).
Exercise and Housing
Provide adequate space for exercise, as physical activity helps maintain appetite and rumen function. Avoid overcrowding and ensure ewes can access feed and water without competition. Housing should be well-ventilated, dry, and free from drafts.
Stress Reduction
Minimize stressors during late gestation:
- Avoid transportation, handling, or mixing of groups
- Provide shelter from extreme weather
- Maintain consistent feeding schedules
- Treat underlying health problems promptly
- Vaccinate and deworm before late gestation
Ultrasound Pregnancy Diagnosis
Use ultrasound pregnancy diagnosis at 45 to 60 days of gestation to identify ewes carrying multiple fetuses. Separate these ewes for enhanced nutrition and monitoring. Ultrasound also identifies non-pregnant ewes that can be culled or managed differently.
Monitoring High-Risk Ewes
Identify and monitor high-risk ewes more frequently during late gestation:
- Ewes carrying triplets or quadruplets
- Ewes with history of pregnancy toxemia
- Aged ewes (over 6 years)
- Ewes with poor body condition or dental problems
- Ewes with lameness or other health issues
Records and Measurements
Individual Ewe Records
Maintain individual records for each ewe including:
- Identification number and breed
- Age and parity
- Body condition scores at key time points
- Pregnancy diagnosis results and fetal number
- Vaccination and deworming history
- Health problems and treatments
- Lambing dates and outcomes
Flock-Level Monitoring
Track flock-level parameters to identify trends and risk factors:
- Incidence of pregnancy toxemia cases per lambing season
- Mortality rates for affected ewes and lambs
- Body condition score distribution across the flock
- Feed intake and ration composition
- Lambing rates and lamb survival
Diagnostic Records
Document diagnostic results for all pregnancy toxemia cases:
- Blood BHB and glucose concentrations
- Urine ketone results
- Physical examination findings
- Treatment administered and response
- Outcome (recovery, death, euthanasia)
Common Failure Patterns
Delayed Recognition
The most common failure in managing pregnancy toxemia is delayed recognition of early clinical signs. Producers may attribute depression and reduced feed intake to normal late gestation behavior. Implement regular monitoring protocols during the high-risk period and train staff to recognize early signs.
Inadequate Energy Supplementation
Underdosing oral energy supplements or providing insufficient frequency of administration leads to treatment failure. Calculate doses based on ewe body weight and repeat dosing at appropriate intervals. Monitor blood BHB to confirm adequate energy supplementation.
Failure to Address Underlying Causes
Treating clinical signs without addressing predisposing factors results in recurrence or poor response. Investigate and correct underlying issues such as inadequate feed quality, competition at the feed bunk, dental disease, or lameness.
Premature Return to Normal Feeding
Rapid introduction of high-concentrate diets after treatment can cause rumen acidosis and relapse. Gradually reintroduce concentrate feeds over 5 to 7 days while monitoring appetite and rumen function.
Neglecting Fetal Viability
Focusing exclusively on the ewe's metabolic status while ignoring fetal health leads to poor lamb survival. Assess fetal viability using ultrasound when possible and plan for appropriate intervention if fetal death is confirmed.
Welfare and Safety Context
Animal Welfare Considerations
Pregnancy toxemia causes significant suffering due to metabolic derangement, neurological dysfunction, and pain. Prompt diagnosis and treatment are essential for welfare reasons. Ewes with advanced clinical signs that do not respond to treatment within 48 hours should be euthanized to prevent prolonged suffering.
The World Organisation for Animal Health provides guidance on animal health and welfare standards relevant to managing metabolic diseases in livestock (World Organisation for Animal Health, https://www.woah.org/en/what-we-do/animal-health-and-welfare). Veterinarians should ensure that treatment decisions prioritize animal welfare.
Human Safety Considerations
Handling recumbent ewes requires caution due to the risk of injury from kicking or sudden movements. Use appropriate restraint techniques and seek assistance when needed. Needle-stick injuries during intravenous catheter placement or medication administration pose infection risks. Follow standard precautions for handling blood and body fluids.
Drug Withdrawal Periods
All medications used in treating pregnancy toxemia have established withdrawal periods for meat and milk. Consult product labels and regulatory guidelines for specific withdrawal times. Document all treatments in individual ewe records to ensure compliance with withdrawal requirements.
Professional Escalation Criteria
Refer cases to a veterinary teaching hospital or specialist when:
- Ewe fails to respond to appropriate medical therapy after 48 hours
- Surgical intervention is required but beyond the veterinarian's expertise
- Multiple cases occur in the flock despite prevention efforts
- Diagnostic uncertainty exists despite thorough workup
- Public health concerns arise (e.g., suspected rabies)
Decision Framework for Triage and Treatment Allocation in Pregnancy Toxemia Cases
Managing pregnancy toxemia in a flock requires rapid triage decisions that balance treatment intensity, cost, prognosis, and labor availability. Without a structured decision framework, producers and veterinarians may apply uniform treatment protocols to all affected ewes, leading to poor outcomes in advanced cases and unnecessary expense in mild cases. This section provides a practical triage system based on clinical staging, response monitoring, and resource allocation that complements the diagnostic and treatment protocols described elsewhere in this article.
Clinical Staging System for Triage Decisions
The following staging system categorizes ewes based on objective clinical parameters and guides treatment intensity. This system uses blood beta-hydroxybutyrate (BHB) concentration, blood glucose, mentation status, and ability to stand as the primary classification criteria. Field studies comparing blood BHB measurement devices for diagnosis of subclinical pregnancy toxemia in sheep have validated the use of handheld meters for on-farm staging (Reproduction in Domestic Animals, 2024, https://pubmed.ncbi.nlm.nih.gov/38812426).
Stage 1: Subclinical Toxemia
Criteria:
- Blood BHB 0.8 to 1.6 mmol/L
- Blood glucose 2.0 to 3.0 mmol/L
- Normal mentation and appetite
- Standing and ambulating normally
- No observable neurological signs
Recommended Action:
- Increase concentrate feeding by 0.2 to 0.4 kg per ewe per day
- Provide access to high-quality forage
- Administer oral propylene glycol 60 mL twice daily for 3 to 5 days
- Monitor blood BHB every 48 hours until below 0.8 mmol/L
- No intravenous therapy required
- Prognosis: Excellent with intervention
Stage 2: Mild Clinical Toxemia
Criteria:
- Blood BHB 1.6 to 3.0 mmol/L
- Blood glucose 1.5 to 2.0 mmol/L
- Mild depression, reduced feed intake
- Standing but may separate from flock
- No recumbency or blindness
Recommended Action:
- Administer oral propylene glycol 60 to 100 mL every 8 to 12 hours
- Provide intravenous dextrose 50% at 100 to 200 mL as a single bolus
- Begin fluid therapy with balanced electrolyte solution if dehydrated
- Offer palatable feed (alfalfa hay, grain mix) multiple times daily
- Monitor blood BHB and glucose every 24 hours
- Assess response within 24 hours
- Prognosis: Good with prompt treatment
Stage 3: Moderate Clinical Toxemia
Criteria:
- Blood BHB 3.0 to 6.0 mmol/L
- Blood glucose below 1.5 mmol/L
- Marked depression, anorexia
- Sternal recumbency but can stand with assistance
- Possible mild neurological signs (head pressing, teeth grinding)
Recommended Action:
- Place intravenous jugular catheter
- Administer 50% dextrose 200 to 400 mL intravenously, repeated every 4 to 6 hours or as continuous rate infusion
- Administer oral propylene glycol 100 mL every 8 hours via drench
- Provide intravenous fluids (lactated Ringer's solution) at maintenance rates
- Consider corticosteroid therapy if fetal viability is a concern
- Monitor blood glucose every 4 to 6 hours and BHB every 12 hours
- Assess for improvement within 24 hours
- Prognosis: Guarded to fair
Stage 4: Severe Clinical Toxemia
Criteria:
- Blood BHB above 6.0 mmol/L
- Blood glucose below 1.0 mmol/L or unmeasurable
- Lateral recumbency, unable to stand
- Blindness, opisthotonos, or coma
- Possible seizures
Recommended Action:
- Immediate intravenous access with jugular catheter
- Administer 50% dextrose 400 to 600 mL intravenously slowly
- Begin continuous rate infusion of 5% dextrose in balanced electrolyte solution
- Administer oral propylene glycol 100 mL via stomach tube if swallowing reflex intact
- Consider corticosteroid therapy
- Discuss cesarean section with producer if no improvement within 12 to 24 hours
- Prepare for euthanasia if no response to aggressive therapy within 48 hours
- Prognosis: Poor to grave
Treatment Allocation Based on Flock Resources
The triage system must account for available labor, facilities, and financial resources. A flock with 50 ewes and one shepherd cannot provide the same level of intensive care as a flock with dedicated hospital pens and multiple staff members. The following allocation framework helps match treatment intensity to available resources.
Resource Category A: Limited Labor and Facilities
Characteristics:
- Single operator managing the flock
- No dedicated hospital pen
- Limited ability to provide intravenous therapy
- Budget constraints for veterinary calls
Recommended Approach:
- Focus on early detection through regular monitoring
- Treat Stage 1 and Stage 2 cases aggressively with oral therapy
- For Stage 3 cases, attempt oral therapy and single intravenous dextrose bolus
- Euthanize Stage 4 cases promptly to prevent suffering
- Prioritize prevention over treatment
- Consider culling ewes that develop toxemia to reduce future risk
Resource Category B: Moderate Labor and Facilities
Characteristics:
- Two to three staff members available
- Dedicated hospital pen with clean bedding
- Ability to provide intravenous fluids
- Regular veterinary access
Recommended Approach:
- Treat Stage 1 through Stage 3 cases with full protocols
- Attempt medical therapy for Stage 4 cases for 24 hours
- Consider cesarean section for valuable ewes at Stage 3 or early Stage 4
- Monitor treated ewes every 4 to 6 hours
- Document all treatments and outcomes
Resource Category C: Intensive Care Capability
Characteristics:
- Multiple trained staff members
- Fully equipped hospital facility
- 24-hour monitoring capability
- Immediate veterinary access
Recommended Approach:
- Treat all stages with maximum medical therapy
- Perform cesarean section when indicated
- Provide intensive nursing care including assisted feeding and turning
- Monitor fetal viability with ultrasound
- Maintain detailed records for research and prevention planning
Response Monitoring and Escalation Protocol
Treatment response must be assessed at defined intervals to determine whether to continue, escalate, or withdraw therapy. The following protocol provides objective criteria for these decisions.
12-Hour Assessment
Parameters to Evaluate:
- Blood BHB concentration
- Blood glucose concentration
- Ability to stand or improvement in posture
- Appetite and interest in feed
- Mentation and response to stimuli
Decision Points:
- If BHB decreased by at least 20% and glucose normalized: Continue current therapy
- If BHB unchanged or increased: Escalate treatment intensity
- If ewe is recumbent and BHB above 6.0 mmol/L: Discuss cesarean section or euthanasia
24-Hour Assessment
Parameters to Evaluate:
- Blood BHB concentration
- Blood glucose concentration
- Ability to stand unassisted
- Feed intake
- Urine ketone levels
Decision Points:
- If BHB below 1.6 mmol/L and ewe standing: Transition to oral therapy and reduce monitoring
- If BHB 1.6 to 3.0 mmol/L with some improvement: Continue intensive therapy
- If BHB above 3.0 mmol/L with no improvement: Escalate to surgical intervention or euthanasia
- If ewe remains recumbent: Prognosis poor, consider euthanasia
48-Hour Assessment
Parameters to Evaluate:
- Blood BHB concentration
- Blood glucose concentration
- Ability to stand and walk
- Appetite and rumen function
- Overall clinical trajectory
Decision Points:
- If BHB below 1.6 mmol/L and ewe eating and standing: Discontinue intravenous therapy, continue oral supplementation for 3 to 5 days
- If BHB 1.6 to 3.0 mmol/L with slow improvement: Continue therapy but consider reducing intensity
- If BHB above 3.0 mmol/L or no improvement: Euthanasia recommended
- If ewe remains recumbent: Euthanasia recommended
Record System for Triage and Treatment Tracking
A standardized record system enables objective tracking of individual ewe response and flock-level patterns. The following template captures essential data for clinical decision-making and prevention planning.
Individual Ewe Treatment Record
Ewe Identification:
- Ear tag number or electronic ID
- Breed and age
- Parity and number of fetuses
- Body condition score at diagnosis
Initial Presentation:
- Date and time of diagnosis
- Clinical stage at presentation
- Blood BHB concentration
- Blood glucose concentration
- Urine ketone result
- Ability to stand (yes/no)
- Mentation score (1=normal, 2=mild depression, 3=marked depression, 4=obtunded, 5=comatose)
Treatment Log:
- Date and time of each treatment
- Type of treatment (oral propylene glycol, intravenous dextrose, fluids, corticosteroids)
- Dose administered
- Route of administration
- Person administering treatment
Monitoring Log:
- Date and time of each assessment
- Blood BHB concentration
- Blood glucose concentration
- Urine ketone result
- Ability to stand
- Mentation score
- Feed intake (none, partial, normal)
- Rumen motility (absent, reduced, normal)
Outcome:
- Date of recovery or death
- Final blood BHB and glucose at recovery
- Lamb survival (both alive, one alive, both dead)
- Days from diagnosis to recovery
- Total treatment cost
- Disposition (returned to flock, culled, euthanized)
Flock-Level Summary Record
Seasonal Data:
- Total ewes at risk
- Number of pregnancy toxemia cases by stage
- Incidence rate (cases per 100 ewes)
- Mortality rate for affected ewes
- Lamb mortality rate
- Average treatment cost per case
- Total economic loss
Risk Factor Analysis:
- Body condition score distribution at breeding and late gestation
- Fetal number distribution (singles, twins, triplets)
- Feeding program details
- Housing and exercise conditions
- Stress events during late gestation
Common Failure Patterns in Triage and Treatment
Failure Pattern 1: Treating All Cases with the Same Protocol
Applying a uniform treatment protocol to all ewes regardless of clinical stage leads to undertreatment of severe cases and overtreatment of mild cases. Stage 1 ewes do not require intravenous therapy, while Stage 4 ewes need aggressive intervention beyond oral supplementation alone. Use the staging system to match treatment intensity to disease severity.
Failure Pattern 2: Delaying Euthanasia Decisions
Producers and veterinarians often continue treatment beyond the point of reasonable expectation for recovery. Ewes that remain recumbent after 48 hours of appropriate therapy have a grave prognosis. Continued treatment prolongs suffering and consumes resources that could be directed toward prevention. Establish clear criteria for euthanasia before beginning treatment and communicate these to all personnel.
Failure Pattern 3: Ignoring Fetal Viability
Treatment decisions that focus exclusively on the ewe's metabolic status without assessing fetal health lead to poor lamb survival. Ewes with severe toxemia often have compromised fetuses that may already be dead. Ultrasound assessment of fetal heart rate and viability should be part of the initial evaluation and ongoing monitoring. Research using pulse wave Doppler ultrasound of the umbilical cord in experimentally induced pregnancy toxemia in sheep has demonstrated changes in fetal blood flow associated with disease severity (Research in Veterinary Science, 2023, https://pubmed.ncbi.nlm.nih.gov/37235922).
Failure Pattern 4: Inadequate Monitoring Frequency
Monitoring every 24 hours is insufficient for ewes receiving intensive therapy. Blood glucose can fluctuate rapidly in response to treatment, and hypoglycemia can recur within hours of dextrose administration. Ewes in Stage 3 or Stage 4 require monitoring every 4 to 6 hours during the first 48 hours of treatment.
Failure Pattern 5: Premature Discontinuation of Oral Supplementation
Ewes that recover from clinical toxemia remain at risk for relapse if oral energy supplementation is discontinued too early. Continue oral propylene glycol or concentrate feeding for at least 5 to 7 days after blood BHB normalizes. Gradually reduce supplementation over 3 to 5 days while monitoring for signs of recurrence.
Practical Implementation Steps for Producers
Step 1: Establish Baseline Monitoring
Begin blood BHB monitoring of high-risk ewes at 4 weeks before expected lambing. Test a representative sample of ewes carrying twins or triplets to establish flock baseline values. Identify ewes with BHB above 0.8 mmol/L for increased monitoring.
Step 2: Train Staff on Staging System
Provide training to all personnel involved in ewe care on the clinical staging system. Use photographs and video examples to illustrate the differences between stages. Practice using handheld BHB meters and interpreting results.
Step 3: Prepare Treatment Kits
Assemble treatment kits for each stage of disease. Include oral propylene glycol, intravenous dextrose, catheters, fluids, and monitoring equipment. Label kits clearly and store in accessible locations.
Step 4: Establish Communication Protocols
Define who makes treatment escalation decisions and when veterinary consultation is required. Post contact information for emergency veterinary services. Establish a chain of command for after-hours decisions.
Step 5: Review Outcomes Annually
At the end of each lambing season, review treatment records and outcomes. Calculate incidence rates, mortality rates, and treatment costs. Identify patterns that suggest opportunities for prevention improvement.
Welfare Considerations in Triage Decisions
The triage framework must prioritize animal welfare alongside treatment success. Ewes with Stage 4 toxemia experience significant suffering from metabolic derangement, neurological dysfunction, and pain. Research evaluating metabolic and oxidative profiles in ovine pregnancy toxemia has demonstrated associations between specific biomarkers and disease prognosis (Tropical Animal Health and Production, 2022, https://pubmed.ncbi.nlm.nih.gov/36210359). Ewes with poor prognostic indicators should be euthanized promptly instead of subjected to prolonged treatment with low likelihood of success.
The World Organisation for Animal Health provides guidance on animal health and welfare standards relevant to managing metabolic diseases in livestock (World Organisation for Animal Health, https://www.woah.org/en/what-we-do/animal-health-and-welfare). Veterinarians should ensure that treatment decisions prioritize animal welfare and that euthanasia is performed humanely when indicated.
Professional Escalation Criteria
Refer cases to a veterinary teaching hospital or specialist when:
- Multiple Stage 3 or Stage 4 cases occur in the same flock within a single lambing season
- Flock incidence exceeds 5% despite implementation of prevention strategies
- Ewes fail to respond to appropriate therapy within 48 hours
- Surgical intervention is required but beyond the veterinarian's expertise
- Diagnostic uncertainty exists despite thorough workup
- Public health concerns arise (e.g., suspected rabies or other zoonotic disease)
Decision Framework for Triage and Treatment Allocation in Pregnancy Toxemia Cases
Managing pregnancy toxemia in a flock requires rapid triage decisions that balance treatment intensity, cost, prognosis, and labor availability. Without a structured decision framework, producers and veterinarians may apply uniform treatment protocols to all affected ewes, leading to poor outcomes in advanced cases and unnecessary expense in mild cases. This section provides a practical triage system based on clinical staging, response monitoring, and resource allocation that complements the diagnostic and treatment protocols described elsewhere in this article.
Clinical Staging System for Triage Decisions
The following staging system categorizes ewes based on objective clinical parameters and guides treatment intensity. This system uses blood beta-hydroxybutyrate (BHB) concentration, blood glucose, mentation status, and ability to stand as the primary classification criteria. Field studies comparing blood BHB measurement devices for diagnosis of subclinical pregnancy toxemia in sheep have validated the use of handheld meters for on-farm staging (Reproduction in Domestic Animals, 2024, https://pubmed.ncbi.nlm.nih.gov/38812426).
Stage 1: Subclinical Toxemia
Criteria:
- Blood BHB 0.8 to 1.6 mmol/L
- Blood glucose 2.0 to 3.0 mmol/L
- Normal mentation and appetite
- Standing and ambulating normally
- No observable neurological signs
Recommended Action:
- Increase concentrate feeding by 0.2 to 0.4 kg per ewe per day
- Provide access to high-quality forage
- Administer oral propylene glycol 60 mL twice daily for 3 to 5 days
- Monitor blood BHB every 48 hours until below 0.8 mmol/L
- No intravenous therapy required
- Prognosis: Excellent with intervention
Stage 2: Mild Clinical Toxemia
Criteria:
- Blood BHB 1.6 to 3.0 mmol/L
- Blood glucose 1.5 to 2.0 mmol/L
- Mild depression, reduced feed intake
- Standing but may separate from flock
- No recumbency or blindness
Recommended Action:
- Administer oral propylene glycol 60 to 100 mL every 8 to 12 hours
- Provide intravenous dextrose 50% at 100 to 200 mL as a single bolus
- Begin fluid therapy with balanced electrolyte solution if dehydrated
- Offer palatable feed (alfalfa hay, grain mix) multiple times daily
- Monitor blood BHB and glucose every 24 hours
- Assess response within 24 hours
- Prognosis: Good with prompt treatment
Stage 3: Moderate Clinical Toxemia
Criteria:
- Blood BHB 3.0 to 6.0 mmol/L
- Blood glucose below 1.5 mmol/L
- Marked depression, anorexia
- Sternal recumbency but can stand with assistance
- Possible mild neurological signs (head pressing, teeth grinding)
Recommended Action:
- Place intravenous jugular catheter
- Administer 50% dextrose 200 to 400 mL intravenously, repeated every 4 to 6 hours or as continuous rate infusion
- Administer oral propylene glycol 100 mL every 8 hours via drench
- Provide intravenous fluids (lactated Ringer's solution) at maintenance rates
- Consider corticosteroid therapy if fetal viability is a concern
- Monitor blood glucose every 4 to 6 hours and BHB every 12 hours
- Assess for improvement within 24 hours
- Prognosis: Guarded to fair
Stage 4: Severe Clinical Toxemia
Criteria:
- Blood BHB above 6.0 mmol/L
- Blood glucose below 1.0 mmol/L or unmeasurable
- Lateral recumbency, unable to stand
- Blindness, opisthotonos, or coma
- Possible seizures
Recommended Action:
- Immediate intravenous access with jugular catheter
- Administer 50% dextrose 400 to 600 mL intravenously slowly
- Begin continuous rate infusion of 5% dextrose in balanced electrolyte solution
- Administer oral propylene glycol 100 mL via stomach tube if swallowing reflex intact
- Consider corticosteroid therapy
- Discuss cesarean section with producer if no improvement within 12 to 24 hours
- Prepare for euthanasia if no response to aggressive therapy within 48 hours
- Prognosis: Poor to grave
Treatment Allocation Based on Flock Resources
The triage system must account for available labor, facilities, and financial resources. A flock with 50 ewes and one shepherd cannot provide the same level of intensive care as a flock with dedicated hospital pens and multiple staff members. The following allocation framework helps match treatment intensity to available resources.
Resource Category A: Limited Labor and Facilities
Characteristics:
- Single operator managing the flock
- No dedicated hospital pen
- Limited ability to provide intravenous therapy
- Budget constraints for veterinary calls
Recommended Approach:
- Focus on early detection through regular monitoring
- Treat Stage 1 and Stage 2 cases aggressively with oral therapy
- For Stage 3 cases, attempt oral therapy and single intravenous dextrose bolus
- Euthanize Stage 4 cases promptly to prevent suffering
- Prioritize prevention over treatment
- Consider culling ewes that develop toxemia to reduce future risk
Resource Category B: Moderate Labor and Facilities
Characteristics:
- Two to three staff members available
- Dedicated hospital pen with clean bedding
- Ability to provide intravenous fluids
- Regular veterinary access
Recommended Approach:
- Treat Stage 1 through Stage 3 cases with full protocols
- Attempt medical therapy for Stage 4 cases for 24 hours
- Consider cesarean section for valuable ewes at Stage 3 or early Stage 4
- Monitor treated ewes every 4 to 6 hours
- Document all treatments and outcomes
Resource Category C: Intensive Care Capability
Characteristics:
- Multiple trained staff members
- Fully equipped hospital facility
- 24-hour monitoring capability
- Immediate veterinary access
Recommended Approach:
- Treat all stages with maximum medical therapy
- Perform cesarean section when indicated
- Provide intensive nursing care including assisted feeding and turning
- Monitor fetal viability with ultrasound
- Maintain detailed records for research and prevention planning
Response Monitoring and Escalation Protocol
Treatment response must be assessed at defined intervals to determine whether to continue, escalate, or withdraw therapy. The following protocol provides objective criteria for these decisions.
12-Hour Assessment
Parameters to Evaluate:
- Blood BHB concentration
- Blood glucose concentration
- Ability to stand or improvement in posture
- Appetite and interest in feed
- Mentation and response to stimuli
Decision Points:
- If BHB decreased by at least 20% and glucose normalized: Continue current therapy
- If BHB unchanged or increased: Escalate treatment intensity
- If ewe is recumbent and BHB above 6.0 mmol/L: Discuss cesarean section or euthanasia
24-Hour Assessment
Parameters to Evaluate:
- Blood BHB concentration
- Blood glucose concentration
- Ability to stand unassisted
- Feed intake
- Urine ketone levels
Decision Points:
- If BHB below 1.6 mmol/L and ewe standing: Transition to oral therapy and reduce monitoring
- If BHB 1.6 to 3.0 mmol/L with some improvement: Continue intensive therapy
- If BHB above 3.0 mmol/L with no improvement: Escalate to surgical intervention or euthanasia
- If ewe remains recumbent: Prognosis poor, consider euthanasia
48-Hour Assessment
Parameters to Evaluate:
- Blood BHB concentration
- Blood glucose concentration
- Ability to stand and walk
- Appetite and rumen function
- Overall clinical trajectory
Decision Points:
- If BHB below 1.6 mmol/L and ewe eating and standing: Discontinue intravenous therapy, continue oral supplementation for 3 to 5 days
- If BHB 1.6 to 3.0 mmol/L with slow improvement: Continue therapy but consider reducing intensity
- If BHB above 3.0 mmol/L or no improvement: Euthanasia recommended
- If ewe remains recumbent: Euthanasia recommended
Record System for Triage and Treatment Tracking
A standardized record system enables objective tracking of individual ewe response and flock-level patterns. The following template captures essential data for clinical decision-making and prevention planning.
Individual Ewe Treatment Record
Ewe Identification:
- Ear tag number or electronic ID
- Breed and age
- Parity and number of fetuses
- Body condition score at diagnosis
Initial Presentation:
- Date and time of diagnosis
- Clinical stage at presentation
- Blood BHB concentration
- Blood glucose concentration
- Urine ketone result
- Ability to stand (yes/no)
- Mentation score (1=normal, 2=mild depression, 3=marked depression, 4=obtunded, 5=comatose)
Treatment Log:
- Date and time of each treatment
- Type of treatment (oral propylene glycol, intravenous dextrose, fluids, corticosteroids)
- Dose administered
- Route of administration
- Person administering treatment
Monitoring Log:
- Date and time of each assessment
- Blood BHB concentration
- Blood glucose concentration
- Urine ketone result
- Ability to stand
- Mentation score
- Feed intake (none, partial, normal)
- Rumen motility (absent, reduced, normal)
Outcome:
- Date of recovery or death
- Final blood BHB and glucose at recovery
- Lamb survival (both alive, one alive, both dead)
- Days from diagnosis to recovery
- Total treatment cost
- Disposition (returned to flock, culled, euthanized)
Flock-Level Summary Record
Seasonal Data:
- Total ewes at risk
- Number of pregnancy toxemia cases by stage
- Incidence rate (cases per 100 ewes)
- Mortality rate for affected ewes
- Lamb mortality rate
- Average treatment cost per case
- Total economic loss
Risk Factor Analysis:
- Body condition score distribution at breeding and late gestation
- Fetal number distribution (singles, twins, triplets)
- Feeding program details
- Housing and exercise conditions
- Stress events during late gestation
Common Failure Patterns in Triage and Treatment
Failure Pattern 1: Treating All Cases with the Same Protocol
Applying a uniform treatment protocol to all ewes regardless of clinical stage leads to undertreatment of severe cases and overtreatment of mild cases. Stage 1 ewes do not require intravenous therapy, while Stage 4 ewes need aggressive intervention beyond oral supplementation alone. Use the staging system to match treatment intensity to disease severity.
Failure Pattern 2: Delaying Euthanasia Decisions
Producers and veterinarians often continue treatment beyond the point of reasonable expectation for recovery. Ewes that remain recumbent after 48 hours of appropriate therapy have a grave prognosis. Continued treatment prolongs suffering and consumes resources that could be directed toward prevention. Establish clear criteria for euthanasia before beginning treatment and communicate these to all personnel.
Failure Pattern 3: Ignoring Fetal Viability
Treatment decisions that focus exclusively on the ewe's metabolic status without assessing fetal health lead to poor lamb survival. Ewes with severe toxemia often have compromised fetuses that may already be dead. Ultrasound assessment of fetal heart rate and viability should be part of the initial evaluation and ongoing monitoring. Research using pulse wave Doppler ultrasound of the umbilical cord in experimentally induced pregnancy toxemia in sheep has demonstrated changes in fetal blood flow associated with disease severity (Research in Veterinary Science, 2023, https://pubmed.ncbi.nlm.nih.gov/37235922).
Failure Pattern 4: Inadequate Monitoring Frequency
Monitoring every 24 hours is insufficient for ewes receiving intensive therapy. Blood glucose can fluctuate rapidly in response to treatment, and hypoglycemia can recur within hours of dextrose administration. Ewes in Stage 3 or Stage 4 require monitoring every 4 to 6 hours during the first 48 hours of treatment.
Failure Pattern 5: Premature Discontinuation of Oral Supplementation
Ewes that recover from clinical toxemia remain at risk for relapse if oral energy supplementation is discontinued too early. Continue oral propylene glycol or concentrate feeding for at least 5 to 7 days after blood BHB normalizes. Gradually reduce supplementation over 3 to 5 days while monitoring for signs of recurrence.
Practical Implementation Steps for Producers
Step 1: Establish Baseline Monitoring
Begin blood BHB monitoring of high-risk ewes at 4 weeks before expected lambing. Test a representative sample of ewes carrying twins or triplets to establish flock baseline values. Identify ewes with BHB above 0.8 mmol/L for increased monitoring.
Step 2: Train Staff on Staging System
Provide training to all personnel involved in ewe care on the clinical staging system. Use photographs and video examples to illustrate the differences between stages. Practice using handheld BHB meters and interpreting results.
Step 3: Prepare Treatment Kits
Assemble treatment kits for each stage of disease. Include oral propylene glycol, intravenous dextrose, catheters, fluids, and monitoring equipment. Label kits clearly and store in accessible locations.
Step 4: Establish Communication Protocols
Define who makes treatment escalation decisions and when veterinary consultation is required. Post contact information for emergency veterinary services. Establish a chain of command for after-hours decisions.
Step 5: Review Outcomes Annually
At the end of each lambing season, review treatment records and outcomes. Calculate incidence rates, mortality rates, and treatment costs. Identify patterns that suggest opportunities for prevention improvement.
Welfare Considerations in Triage Decisions
The triage framework must prioritize animal welfare alongside treatment success. Ewes with Stage 4 toxemia experience significant suffering from metabolic derangement, neurological dysfunction, and pain. Research evaluating metabolic and oxidative profiles in ovine pregnancy toxemia has demonstrated associations between specific biomarkers and disease prognosis (Tropical Animal Health and Production, 2022, https://pubmed.ncbi.nlm.nih.gov/36210359). Ewes with poor prognostic indicators should be euthanized promptly instead of subjected to prolonged treatment with low likelihood of success.
The World Organisation for Animal Health provides guidance on animal health and welfare standards relevant to managing metabolic diseases in livestock (World Organisation for Animal Health, https://www.woah.org/en/what-we-do/animal-health-and-welfare). Veterinarians should ensure that treatment decisions prioritize animal welfare and that euthanasia is performed humanely when indicated.
Professional Escalation Criteria
Refer cases to a veterinary teaching hospital or specialist when:
- Multiple Stage 3 or Stage 4 cases occur in the same flock within a single lambing season
- Flock incidence exceeds 5% despite implementation of prevention strategies
- Ewes fail to respond to appropriate therapy within 48 hours
- Surgical intervention is required but beyond the veterinarian's expertise
- Diagnostic uncertainty exists despite thorough workup
- Public health concerns arise (e.g., suspected rabies or other zoonotic disease)
Frequently Asked Questions
What is the difference between subclinical and clinical pregnancy toxemia?
Subclinical pregnancy toxemia is characterized by elevated blood BHB concentrations (0.8 to 1.6 mmol/L) without obvious clinical signs. Affected ewes may show subtle changes in feed intake or behavior that are easily missed. Clinical pregnancy toxemia involves blood BHB above 1.6 mmol/L with observable signs including depression, recumbency, blindness, and neurological dysfunction. Early detection of subclinical cases through routine monitoring improves treatment success and reduces mortality.
How quickly does pregnancy toxemia progress in ewes?
The progression from subclinical to clinical disease varies from days to weeks depending on the severity of energy deficit and individual ewe factors. Once clinical signs appear, deterioration can occur rapidly over 24 to 48 hours. Ewes that become recumbent have a guarded prognosis and require immediate intensive treatment. Early intervention during the subclinical stage offers the best chance for recovery.
Can pregnancy toxemia be prevented through nutrition alone?
Nutrition is the cornerstone of prevention, but it must be combined with other management strategies for optimal results. Proper body condition management, adequate energy intake during late gestation, and gradual ration changes reduce disease risk. However, factors such as stress, concurrent disease, and environmental conditions also influence disease development. A comprehensive prevention program addressing nutrition, housing, exercise, and health management provides the best protection.
What is the prognosis for a ewe with pregnancy toxemia?
Prognosis depends on the severity of clinical signs at presentation and the timeliness of treatment. Ewes treated early in the disease course with mild to moderate signs have a good prognosis for recovery. Ewes that are recumbent, blind, or comatose have a guarded to poor prognosis even with aggressive treatment. Fetal survival is also compromised, with lamb mortality rates increasing as maternal condition worsens.
How do I choose between medical treatment and cesarean section?
Medical treatment is appropriate for ewes with mild to moderate clinical signs that respond to initial therapy. Cesarean section should be considered when medical treatment fails to produce improvement within 24 to 48 hours, when fetal death is confirmed, or when the ewe's condition deteriorates despite appropriate therapy. The decision should involve discussion with the producer regarding costs, prognosis, and future breeding value of the ewe.
What monitoring frequency is recommended for high-risk ewes?
High-risk ewes should be monitored at least twice daily during the last 4 weeks of gestation. Monitoring includes observation of feed intake, behavior, and mobility. Weekly body condition scoring and blood BHB testing can identify developing problems before clinical signs appear. Increase monitoring frequency if any abnormalities are detected.
Can pregnancy toxemia recur in subsequent pregnancies?
Ewes that have experienced pregnancy toxemia are at increased risk for recurrence in future pregnancies. This may be due to underlying metabolic tendencies, management factors, or persistent health issues. Affected ewes should be identified and managed as high-risk in subsequent gestations. Consider culling ewes that experience severe or recurrent episodes.
What are the economic impacts of pregnancy toxemia in a flock?
Economic losses from pregnancy toxemia include direct costs of treatment, mortality of ewes and lambs, reduced lamb survival and growth, and increased labor for monitoring and care. Flocks with high incidence may also experience reduced reproductive performance in subsequent years. Prevention programs that reduce disease incidence typically provide positive economic returns through improved productivity and reduced treatment costs.
Related Veterinary Guides
- Sheep Foot Health And Lameness Prevention
- Beef Cow Pregnancy Diagnosis Records
- Dairy Sheep Production Systems Breeds Milking And Flock Management
- Sheep Farming Flock Nutrition Grazing Lambing Parasite Risk And Welfare
- Goat Health Management Vaccination Biosecurity Disease Prevention
References and Further Reading
- www.acvim.org
- Merck Veterinary Manual. Merck Veterinary Manual.
- Animal Health and Welfare. World Organisation for Animal Health.
- Pregnancy Toxemia in Sheep and Goats.. The Veterinary clinics of North America. Food animal practice, 2023.
- Pregnancy toxemia in a flock of sheep.. Journal of the American Veterinary Medical Association, 2000.
- Pulse wave Doppler ultrasound of umbilical cord in experimentally induced pregnancy toxemia in sheep.. Research in veterinary science, 2023.
- Evaluation of metabolic and oxidative profile in ovine pregnancy toxemia and to determine their association with diagnosis and prognosis of disease.. Tropical animal health and production, 2022.
- Comparison of blood ΒHBA measurement devices for diagnosis of subclinical pregnancy toxaemia in sheep: A field study.. Reproduction in domestic animals = Zuchthygiene, 2024.
- Pregnancy toxemia, abortions, and periparturient diseases.. The Veterinary clinics of North America. Large animal practice, 1983.
- Effects of β-hydroxybutyrate infusion on hind limb metabolism in fetal sheep. American Journal of Obstetrics and Gynecology, 1992.
- Effects of long-term ad libitum feeding on plasma lipid components and blood glucose, beta-hydroxybutyrate and insulin concentrations in lean adult sheep.. Reproduction Nutrition Development, 1983.
- Umbilical V-A Differences of Acetoacetate and β-Hydroxybutyrate in Fed and Starved Ewes. Proceedings of the Society for Experimental Biology and Medicine, 1974.
- Effect of lactate and β-hydroxybutyrate infusions on brain metabolism in the fetal sheep. Journal of Developmental Physiology, 1990.
- Comparison of human sheep chorion laeve permeability to glucose, β-hydroxybutyrate, and glycerol. American Journal of Obstetrics and Gynecology, 1980.
- Autoregulation of Alimentary and Hepatic Ketogenesis in Sheep. Journal of Dairy Science, 1986.
This article is educational and is not a substitute for veterinary diagnosis or treatment. Contact a veterinarian for advice about an individual animal.